NO20022982D0 - Preparat med rask virkningsinntreden - Google Patents
Preparat med rask virkningsinntredenInfo
- Publication number
- NO20022982D0 NO20022982D0 NO20022982A NO20022982A NO20022982D0 NO 20022982 D0 NO20022982 D0 NO 20022982D0 NO 20022982 A NO20022982 A NO 20022982A NO 20022982 A NO20022982 A NO 20022982A NO 20022982 D0 NO20022982 D0 NO 20022982D0
- Authority
- NO
- Norway
- Prior art keywords
- pyridoxine hcl
- doxylamine succinate
- approx
- dissolved
- total
- Prior art date
Links
- 238000002360 preparation method Methods 0.000 title abstract 2
- KBAUFVUYFNWQFM-UHFFFAOYSA-N Doxylamine succinate Chemical compound OC(=O)CCC(O)=O.C=1C=CC=NC=1C(C)(OCCN(C)C)C1=CC=CC=C1 KBAUFVUYFNWQFM-UHFFFAOYSA-N 0.000 abstract 6
- 229960005008 doxylamine succinate Drugs 0.000 abstract 6
- LXNHXLLTXMVWPM-UHFFFAOYSA-N pyridoxine Chemical compound CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 abstract 6
- 235000019171 pyridoxine hydrochloride Nutrition 0.000 abstract 6
- 239000011764 pyridoxine hydrochloride Substances 0.000 abstract 6
- 229940011671 vitamin b6 Drugs 0.000 abstract 6
- 238000005259 measurement Methods 0.000 abstract 4
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 abstract 2
- 239000003795 chemical substances by application Substances 0.000 abstract 2
- RZVAJINKPMORJF-UHFFFAOYSA-N Acetaminophen Chemical compound CC(=O)NC1=CC=C(O)C=C1 RZVAJINKPMORJF-UHFFFAOYSA-N 0.000 abstract 1
- 239000000654 additive Substances 0.000 abstract 1
- 239000011230 binding agent Substances 0.000 abstract 1
- 238000004090 dissolution Methods 0.000 abstract 1
- 239000002702 enteric coating Substances 0.000 abstract 1
- 238000009505 enteric coating Methods 0.000 abstract 1
- 239000000945 filler Substances 0.000 abstract 1
- 239000000314 lubricant Substances 0.000 abstract 1
- 239000008363 phosphate buffer Substances 0.000 abstract 1
- 239000000377 silicon dioxide Substances 0.000 abstract 1
- 239000003381 stabilizer Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2009—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4402—Non condensed pyridines; Hydrogenated derivatives thereof only substituted in position 2, e.g. pheniramine, bisacodyl
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4415—Pyridoxine, i.e. Vitamin B6
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
- A61K9/2846—Poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2886—Dragees; Coated pills or tablets, e.g. with film or compression coating having two or more different drug-free coatings; Tablets of the type inert core-drug layer-inactive layer
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Inorganic Chemistry (AREA)
- Otolaryngology (AREA)
- Hospice & Palliative Care (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Lubricants (AREA)
- Seal Device For Vehicle (AREA)
- Memory System Of A Hierarchy Structure (AREA)
- Power Steering Mechanism (AREA)
Abstract
Tilveiebrakt her er et nytt preparat enterisk coatet pyridoksin HCI og doksylaminsuccinat med rask virkningsinntreden som omfatter et disintegreringsagens slik at de følgende oppløsningsprofilene blir tilfredsstilt når de måles i 1000 ml fosfatbuffer ved pH 6,8 og 37°C i et type 2 oppløsningsapparat ved 100 rpm: (a) minst ca. 40% av det totale pyridoksin HCI og doksylamin succinat er løst etter 30 minutters målinger; (b) minst ca. 70% av det totale pyridoksin HCI og doksylamin succinat er løst etter 60 minutters målinger; (c) minst ca. 80% av det totale pyridoksin HCI og doksylamin succinat er løst etter 90 minutters målinger; (d) ca. 90% av det totale pyridoksin HCI og doksylamin succinat er løst etter 120 minutters målinger. Det er ønskelig at preparatet vil inneholde en kjerne som er coatet med minst en enterisk coating, kjernen omfatter pyridoksin HCI, doksylamin succinat og de følgende ikke aktive tilsetningsstoffene: en fyllmasse eller bindemiddel, et disintegreringsagens, et smøremiddel, en silika strømningsconditioner og et stabiliseringsagens.
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CA002350195A CA2350195C (en) | 2000-12-20 | 2000-12-20 | Rapid onset formulation of pyridoxine hydrochloride and doxylamine succinate |
| PCT/CA2001/000951 WO2003000263A1 (en) | 2000-12-20 | 2001-06-21 | Rapid onset formulation |
| US09/885,051 US6340695B1 (en) | 2000-12-20 | 2001-06-21 | Rapid onset formulation |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| NO20022982D0 true NO20022982D0 (no) | 2002-06-20 |
| NO20022982L NO20022982L (no) | 2002-10-09 |
| NO332190B1 NO332190B1 (no) | 2012-07-23 |
Family
ID=42104724
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20022982A NO332190B1 (no) | 2000-12-20 | 2002-06-20 | Enterisk belagt pyridoksin HCl- og doksylaminsuksinat-preparat med rask virkningsinntreden, anvendelse derav, medikament og fremgangsmate for fremstilling av preparatet. |
Country Status (35)
| Country | Link |
|---|---|
| US (1) | US6340695B1 (no) |
| EP (1) | EP1397133B1 (no) |
| JP (1) | JP4242763B2 (no) |
| KR (1) | KR100527985B1 (no) |
| CN (1) | CN1229112C (no) |
| AT (1) | ATE307582T1 (no) |
| AU (1) | AU2001272243B2 (no) |
| BE (1) | BE1014929A4 (no) |
| BR (1) | BR0107371A (no) |
| CA (1) | CA2350195C (no) |
| DE (2) | DE10196426T1 (no) |
| DK (2) | DK1397133T3 (no) |
| EG (1) | EG24483A (no) |
| ES (1) | ES2251494T3 (no) |
| FI (1) | FI117961B (no) |
| FR (1) | FR2826277B1 (no) |
| GB (1) | GB2383751C (no) |
| GR (1) | GR1004371B (no) |
| HK (1) | HK1052654A1 (no) |
| HU (1) | HU227003B1 (no) |
| IL (1) | IL150349A0 (no) |
| IS (1) | IS2225B (no) |
| IT (1) | ITTO20020524A1 (no) |
| LU (1) | LU90934B1 (no) |
| MC (1) | MC200059A1 (no) |
| MX (1) | MXPA02006037A (no) |
| MY (1) | MY132786A (no) |
| NL (1) | NL1020895C2 (no) |
| NO (1) | NO332190B1 (no) |
| PL (1) | PL204507B1 (no) |
| SE (1) | SE526307C2 (no) |
| TR (1) | TR200201685T1 (no) |
| UA (1) | UA74807C2 (no) |
| UY (1) | UY27352A1 (no) |
| WO (1) | WO2003000263A1 (no) |
Families Citing this family (29)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2350195C (en) * | 2000-12-20 | 2003-06-10 | Duchesnay Inc. | Rapid onset formulation of pyridoxine hydrochloride and doxylamine succinate |
| US8257746B2 (en) | 2001-04-10 | 2012-09-04 | Pernix Therapeutics, Llc | Tannate compositions, methods of making and methods of use |
| US8012506B2 (en) * | 2001-04-10 | 2011-09-06 | Pernix Therapeutics, Llc | Tannate compositions, methods of making and methods of use |
| ES2229876B1 (es) * | 2001-06-26 | 2006-03-01 | Duchesnay Inc. | Formulacion de accion rapida. |
| CA2392486A1 (en) * | 2002-07-05 | 2002-12-08 | Duchesnay Inc. | Pharmaceutical dosage form bearing pregnancy-friendly indicia |
| CA2406592C (en) * | 2002-10-04 | 2003-09-30 | Duchesnay Inc. | Method of preparing pharmaceutical dosage forms containing multiple active ingredients |
| JP2004231520A (ja) * | 2003-01-28 | 2004-08-19 | Nichiko Pharmaceutical Co Ltd | 保存安定性及び溶出速度に優れた医薬組成物 |
| US20050004181A1 (en) * | 2003-07-03 | 2005-01-06 | Duchesnay Inc. | Use of anti-emetic for pre and post operative care |
| EP1830886B1 (en) | 2004-12-27 | 2016-04-13 | Eisai R&D Management Co., Ltd. | Method for stabilizing anti-dementia drug |
| US20090208579A1 (en) * | 2004-12-27 | 2009-08-20 | Eisai R & D Management Co., Ltd. | Matrix Type Sustained-Release Preparation Containing Basic Drug or Salt Thereof, and Method for Manufacturing the Same |
| US20060280789A1 (en) * | 2004-12-27 | 2006-12-14 | Eisai Research Institute | Sustained release formulations |
| US20070129402A1 (en) * | 2004-12-27 | 2007-06-07 | Eisai Research Institute | Sustained release formulations |
| CN101166543B (zh) * | 2005-04-28 | 2014-07-16 | 卫材R&D管理有限公司 | 含抗痴呆药物的组合物 |
| US20070277530A1 (en) * | 2006-05-31 | 2007-12-06 | Constantin Alexandru Dinu | Inlet flow conditioner for gas turbine engine fuel nozzle |
| CN102108059B (zh) * | 2010-09-03 | 2012-05-09 | 合肥工业大学 | 一种琥珀酸多西拉敏的合成方法 |
| US8950188B2 (en) | 2011-09-09 | 2015-02-10 | General Electric Company | Turning guide for combustion fuel nozzle in gas turbine and method to turn fuel flow entering combustion chamber |
| SG11201403931YA (en) | 2012-02-22 | 2014-08-28 | Duchesnay Inc | Formulation of doxylamine and pyridoxine and/or metabolites or salts thereof |
| WO2013123569A1 (en) * | 2012-02-22 | 2013-08-29 | Duchesnay Inc. | Formulation of doxylamine and pyridoxine and/or metabolites or salts thereof |
| US10952968B2 (en) | 2012-05-14 | 2021-03-23 | Shionogi & Co., Ltd. | Preparation containing 6,7-unsaturated-7-carbamoyl morphinan derivatives |
| US9452181B2 (en) | 2013-07-22 | 2016-09-27 | Duchesnay Inc. | Composition for the management of nausea and vomiting |
| EP3024466B1 (en) * | 2013-07-22 | 2018-04-04 | Duchesnay Inc. | Composition for the management of nausea and vomiting |
| CN103432126A (zh) * | 2013-08-05 | 2013-12-11 | 北京阜康仁生物制药科技有限公司 | 一种治疗孕吐的药物组合物 |
| TWI595874B (zh) | 2014-08-29 | 2017-08-21 | 達契斯奈股份有限公司 | 多西拉敏及吡哆醇及／或其代謝產物或鹽之多模式釋放調配物 |
| JP6272561B2 (ja) | 2014-08-29 | 2018-01-31 | デュシネイ・インコーポレイテッド | ドキシラミン並びにピリドキシン及び／またはそれらの代謝産物もしくは塩の多峰性放出製剤 |
| WO2017029573A1 (en) | 2015-08-17 | 2017-02-23 | Aequus Pharmaceuticals Inc. | Transdermal delivery of doxylamine succinate and pyridoxine hydrochloride |
| CN105510512B (zh) * | 2016-01-25 | 2018-06-29 | 南京济群医药科技股份有限公司 | 一种琥珀酸多西拉敏有关物质的rt-hplc检测方法 |
| ES2847648T3 (es) * | 2018-09-27 | 2021-08-03 | Inibsa Ginecologia S A | Procedimiento para la preparación de una forma de dosificación oral de múltiples unidades de liberación modificada de succinato de doxilamina y clorhidrato de piridoxina |
| CN114099450A (zh) * | 2020-08-31 | 2022-03-01 | 长春海悦药业股份有限公司 | 一种比拉斯汀片及其制备方法 |
| AU2021225255B1 (en) * | 2021-09-03 | 2022-06-16 | Patel, Mihir MR | Compositions, kits, and methods to provide synergistic and/or additive effects from comprised ingredients for the prevention, treatment and management of nausea and vomiting. |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2085641A1 (en) * | 1970-04-20 | 1971-12-31 | Investigations Sci Pharm | Noramidopyrine doxylamine succinate compsn - antiinflammatories analgesics and antipyretics |
| US4642231A (en) * | 1983-07-20 | 1987-02-10 | Warner-Lambert Company | Magnesium trisilicate suitable for preparation of medicament adsorbates of antihistamines |
| EP0620728B1 (en) * | 1992-01-13 | 1997-01-08 | Pfizer Inc. | Preparation of tablets of increased strength |
| CA2139896C (en) * | 1995-01-10 | 2000-03-28 | Don B. Mcdonah | Use of antinauseant agent for terminally ill humans |
| US6013280A (en) * | 1997-10-07 | 2000-01-11 | Fuisz Technologies Ltd. | Immediate release dosage forms containing microspheres |
| WO2001019901A2 (en) * | 1999-09-14 | 2001-03-22 | Smithkline Beecham Corporation | Process for making aqueous coated beadlets |
| CA2350195C (en) * | 2000-12-20 | 2003-06-10 | Duchesnay Inc. | Rapid onset formulation of pyridoxine hydrochloride and doxylamine succinate |
-
2000
- 2000-12-20 CA CA002350195A patent/CA2350195C/en not_active Expired - Lifetime
-
2001
- 2001-06-21 HU HU0301950A patent/HU227003B1/hu unknown
- 2001-06-21 IL IL15034901A patent/IL150349A0/xx active IP Right Grant
- 2001-06-21 DE DE10196426T patent/DE10196426T1/de not_active Ceased
- 2001-06-21 DE DE60114475T patent/DE60114475T2/de not_active Expired - Lifetime
- 2001-06-21 BR BR0107371-0A patent/BR0107371A/pt not_active Application Discontinuation
- 2001-06-21 PL PL362763A patent/PL204507B1/pl unknown
- 2001-06-21 GB GB0213990A patent/GB2383751C/en not_active Expired - Lifetime
- 2001-06-21 EP EP01951259A patent/EP1397133B1/en not_active Expired - Lifetime
- 2001-06-21 AU AU2001272243A patent/AU2001272243B2/en not_active Expired
- 2001-06-21 US US09/885,051 patent/US6340695B1/en not_active Expired - Lifetime
- 2001-06-21 MX MXPA02006037A patent/MXPA02006037A/es active IP Right Grant
- 2001-06-21 JP JP2003506908A patent/JP4242763B2/ja not_active Expired - Fee Related
- 2001-06-21 ES ES01951259T patent/ES2251494T3/es not_active Expired - Lifetime
- 2001-06-21 AT AT01951259T patent/ATE307582T1/de active
- 2001-06-21 TR TR2002/01685T patent/TR200201685T1/xx unknown
- 2001-06-21 KR KR10-2002-7009679A patent/KR100527985B1/ko active IP Right Review Request
- 2001-06-21 UA UA2002065093A patent/UA74807C2/uk unknown
- 2001-06-21 WO PCT/CA2001/000951 patent/WO2003000263A1/en active IP Right Grant
- 2001-06-21 DK DK01951259T patent/DK1397133T3/da active
- 2001-06-21 CN CNB018145485A patent/CN1229112C/zh not_active Expired - Fee Related
-
2002
- 2002-06-07 IS IS6412A patent/IS2225B/is unknown
- 2002-06-12 GR GR20020100280A patent/GR1004371B/el unknown
- 2002-06-18 NL NL1020895A patent/NL1020895C2/nl not_active IP Right Cessation
- 2002-06-18 IT IT2002TO000524A patent/ITTO20020524A1/it unknown
- 2002-06-19 MY MYPI20022296A patent/MY132786A/en unknown
- 2002-06-19 EG EG2002060693A patent/EG24483A/xx active
- 2002-06-20 MC MC2486A patent/MC200059A1/xx unknown
- 2002-06-20 NO NO20022982A patent/NO332190B1/no not_active IP Right Cessation
- 2002-06-20 DK DK200200947A patent/DK176018B1/da not_active IP Right Cessation
- 2002-06-20 FR FR0207643A patent/FR2826277B1/fr not_active Expired - Lifetime
- 2002-06-20 BE BE2002/0397A patent/BE1014929A4/fr not_active IP Right Cessation
- 2002-06-21 LU LU90934A patent/LU90934B1/fr active
- 2002-06-21 UY UY27352A patent/UY27352A1/es not_active Application Discontinuation
- 2002-07-03 SE SE0202061A patent/SE526307C2/sv unknown
- 2002-09-25 FI FI20021708A patent/FI117961B/fi not_active IP Right Cessation
-
2003
- 2003-07-11 HK HK03105025A patent/HK1052654A1/xx not_active IP Right Cessation
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20022982D0 (no) | Preparat med rask virkningsinntreden | |
| BR0212048A (pt) | Composição de pelìcula oralmente consumìvel para a liberação de agentes refrescantes do hálito para a cavidade oral, e, método para liberação de um agente refrescante do hálito para a cavidade oral | |
| RS51903B (sr) | Formulacija aripiprazol kompleksa i postupak | |
| ATE450250T1 (de) | Stabile zusammensetzung enhaltend partikel in einer gefrorenen wässrigen matrix | |
| AR016658A1 (es) | UN ADITIVO MULTIFUNCIONAL uTIL EN CEMENTACIoN DE POZOS, UNA COMPOSICIoN DE CEMENTO QUE COMPRENDE DICHO ADITIVO, UN MÉTODO PARA FABRICARLO, UN MÉTODO PARA REDUCIR LA APARICIoN DE CANALIZACIoN DE GAS EN EL CEMENTO Y UN MÉTODO PARA ESTABILIZAR LA ESPUMA CREADA POR LA ADICIoN DE GAS NITRoGENO A UNA COMP | |
| BRPI0407352A (pt) | Composição para o cuidado oral, e, métodos para efetuar a estabilidade aumentada em uma composição oral contendo enzimas, e para a preparação de uma composição para o cuidado oral aquosa | |
| BR0109729A (pt) | Uso de uma combinação de um agente anti-angiogênico e um agente anti-hipertensivo, kit para uso na produção de um efeito anti-angiogênico e/ou efeito redutor da permeabilidade vascular em um animal de sangue quente, e, método de tratamento de um estado doentio associado com a angiogênese | |
| MY135609A (en) | Pharmaceutical formulation of iressa comprising a water-soluble cellulose derivative | |
| BR0312293A (pt) | Método para promover a abstinência do fumo | |
| BR9809049B1 (pt) | mÉtodo para modificar as propriedades de trabalhabilidade de uma argamassa de cimento; e composiÇço de argamassa de cimento. | |
| IS2369B (is) | Ný blanda 5-HT4 gerandefna eða mótlyfja til inntöku um munn | |
| DK1079843T3 (da) | Anvendelse af a1beta1 integrinreceptorinhibitorer og TFG beta1 inhibitorer til behandling af nyresygdom | |
| DE50112147D1 (de) | Faserfreies, nicht brennbares, geschäumtes Isolier- und Brandschutzmaterial und Verfahren zu seiner Herstellung | |
| NO20001937D0 (no) | 2-substituerte 1,2-benzisotiazol-derivater og deres anvendelse som serotonin-antagonister (5-HT1A, 5-HT1B og 5-HT1D) | |
| AR034380A1 (es) | Formulacion de accion rapida | |
| ES2181429T3 (es) | Agente anticontraccion para hormigon o mortero. | |
| IS2446B (is) | Nýtt galenskt form til inngjafar um munn með hægri losun á molsidómíni. | |
| NO20004075D0 (no) | Substituerte pyrimidin-2-yloksy-karboksylsyrederivater, fremstilling av disse og deres anvendelse som endotelin- antagonister | |
| Thorpe | Burning issues | |
| UA37843A (uk) | Спосіб реконструкції багатоповерхових будинків | |
| UA35999A (uk) | Будівельний розчин для оздоблювальних робіт |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MK1K | Patent expired |